Pursuant to Regulation 30 of the Listing Regulations, Ajanta Pharma has informed that Purushottam B. Agrawal, has resigned as Director of the Company on 11th August 2018, with immediate effect. He has been associated with the Company since inception of the Company and has resigned on his own accord. The company regret the delay in intimation as management was in discussions on this subject.
The above information is a part of company’s filings submitted to BSE.